Otonomy to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 16 2021 - 7:30AM
Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced its participation in the Piper Sandler
33rd Annual Virtual Healthcare Conference. Management will
participate in a pre-recorded company fireside chat, which will be
available on the conference website beginning at 10 a.m. ET / 7
a.m. PT on November 22, 2021.
A link to the fireside chat will also become available at the
same time through the Events page of the company's website
(www.otonomy.com).
Otonomy will be participating in 1x1 meetings with investors on
Wednesday, December 1, and meetings can be requested exclusively
via Piper Sandler.
About OtonomyOtonomy is a biopharmaceutical
company dedicated to the development of innovative therapeutics for
neurotology. The company pioneered the application of drug delivery
technology to the ear in order to develop products that achieve
sustained drug exposure from a single local administration. This
approach is covered by a broad patent estate and is being utilized
to develop a pipeline of products addressing important unmet
medical needs with a focus on hearing loss and tinnitus. For
additional information please visit www.otonomy.com.
Contacts:
Media Inquiries:Spectrum ScienceChloé-Anne RamseyVice
President404.865.3601cramsey@spectrumscience.com
Investor Inquiries:Westwicke ICRRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From May 2024 to Jun 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2023 to Jun 2024